Back to search

University of British Columbia

Fibroblast activation protein and the progression of low-grade serous ovarian cancer

Abstract

dc:description

Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy. Among the five histologically distinct types of EOC, low-grade serous ovarian carcinoma (LGSC) is among the rarest with an incidence of 5%, compared to the high-grade serous ovarian carcinoma (HGSC) standing on an incidence of 70%. The low incidence of LGSC has contributed to it being underrepresented in EOC research endeavours. The current therapeutic options provided to LGSC patients are chemotherapy, either paclitaxel, carboplatin, or a combination. Yet, the disease is refractory to these treatments. As conventional treatment is not effective at prolonging survival of LGSC patients, alternative approached must be explored. Here, we investigate the proteome of LGSC, its precursor lesion serous borderline tumour (SBT) to identify novel prognostic and therapeutic targets against LGSC. Fibroblast Activation Protein (FAP) was identified as the most differentially abundant protein in LGSC relative to SBT. FAP is widely expressed and recognized protein in epithelial cancers, marking the presence of a cancer-associated fibroblasts (CAFs). FAP+ CAFs have been associated with the T regulatory cells, a population of immune cells that foster an immunosuppressive microenvironment, in breast cancer. That correlation was also observed in LGSC through scoring of FOXP3+ cells via immunohistochemistry. Our proteomic cohort reveals that FAP is present in the stroma of LGSC and is correlated with T regulatory cells, presenting the potential to translate treatment approaches that target FAP to this cancer.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Genome Science and Technology
Grantor dc:publisher
University of British Columbia
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Vallejos, Rodrigo
Contributors dc:contributor
  • Huntsman, David G.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/89731

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Vallejos, Rodrigo. Fibroblast activation protein and the progression of low-grade serous ovarian cancer. master's thesis, University of British Columbia, 2024. http://hdl.handle.net/2429/89731